Theagene Jean-Manasse 4
4 · MAIA Biotechnology, Inc. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2024-09-30+7,232→ 7,232 totalExercise: $2.81From: 2024-09-30Exp: 2034-09-30→ Common Stock (7,232 underlying)
Footnotes (1)
- [F1]The stock options, granted on September 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of thate date.